Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Marsch

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
JMIR Mental Health|May 10, 2022
Momentary Self-regulation: Scale Development and Preliminary ValidationEmily A Scherer, Sunny Jung Kim, Stephen A Metcalf, et al.
IEEE Security & Privacy|November 8, 2014
Securing Information Technology in HealthcareDenise Anthony, Andrew T Campbell, Thomas Candon, et al.
Journal of Medical Internet Research|June 9, 2025
Information Needs for Opioid Use Disorder Treatment Using Buprenorphine Product: Qualitative Analysis of Suboxone-Focused Reddit DataMadhusudan Basak, Omar Sharif, Sarah E Lord, et al.
Addiction Science & Clinical Practice|November 18, 2024
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paperGerald T Cochran, Jennifer L Brown, Ziji Yu, et al.
Journal of Medical Internet Research|March 11, 2022
Scale-up of Digital Innovations in Health Care: Expert Commentary on Enablers and BarriersHannes Schlieter, Lisa A Marsch, Diane Whitehouse, et al.
Journal of Addictive Diseases|June 28, 2007
Outcomes of buprenorphine maintenance in office-based practiceStephen Magura, Stephen J Lee, Edwin A Salsitz, et al.
Journal of Opioid Management|December 25, 2012
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocolAndrew Rosenblum, Ricardo A Cruciani, Eric C Strain, et al.
Addiction (Abingdon, England)|February 27, 2016
A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adultsLisa A Marsch, Sarah K Moore, Jacob T Borodovsky, et al.
JAMIA Open|July 5, 2022
Enhancing research data infrastructure to address the opioid epidemic: the Opioid Overdose Network (O2-Net)Leslie A Lenert, Vivienne Zhu, Lindsey Jennings, et al.
Revista Colombiana De Psiquiatria (English Ed.)|July 20, 2021
Barriers and facilitators to the diagnosis and treatment of depression in primary care in Colombia: Perspectives of providers, healthcare administrators, patients and community representativesSophia M Bartels, Paula Cardenas, José M Uribe-Restrepo, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
JMIR Mental Health|May 10, 2022
Momentary Self-regulation: Scale Development and Preliminary ValidationEmily A Scherer, Sunny Jung Kim, Stephen A Metcalf, et al.
IEEE Security & Privacy|November 8, 2014
Securing Information Technology in HealthcareDenise Anthony, Andrew T Campbell, Thomas Candon, et al.
Journal of Medical Internet Research|June 9, 2025
Information Needs for Opioid Use Disorder Treatment Using Buprenorphine Product: Qualitative Analysis of Suboxone-Focused Reddit DataMadhusudan Basak, Omar Sharif, Sarah E Lord, et al.
Addiction Science & Clinical Practice|November 18, 2024
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool-a protocol paperGerald T Cochran, Jennifer L Brown, Ziji Yu, et al.
Journal of Medical Internet Research|March 11, 2022
Scale-up of Digital Innovations in Health Care: Expert Commentary on Enablers and BarriersHannes Schlieter, Lisa A Marsch, Diane Whitehouse, et al.
Journal of Addictive Diseases|June 28, 2007
Outcomes of buprenorphine maintenance in office-based practiceStephen Magura, Stephen J Lee, Edwin A Salsitz, et al.
Journal of Opioid Management|December 25, 2012
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocolAndrew Rosenblum, Ricardo A Cruciani, Eric C Strain, et al.
Addiction (Abingdon, England)|February 27, 2016
A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adultsLisa A Marsch, Sarah K Moore, Jacob T Borodovsky, et al.
JAMIA Open|July 5, 2022
Enhancing research data infrastructure to address the opioid epidemic: the Opioid Overdose Network (O2-Net)Leslie A Lenert, Vivienne Zhu, Lindsey Jennings, et al.
Revista Colombiana De Psiquiatria (English Ed.)|July 20, 2021
Barriers and facilitators to the diagnosis and treatment of depression in primary care in Colombia: Perspectives of providers, healthcare administrators, patients and community representativesSophia M Bartels, Paula Cardenas, José M Uribe-Restrepo, et al.
Pageof 19